Page last updated: 2024-11-11

ginnalin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ginnalin A: isolated from Acer pycnanthum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AcergenusA plant genus of the family SAPINDACEAE, best known for trees with palmately lobed leaves.[MeSH]SapindaceaeThe soapberry plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Some members contain SAPONINS.[MeSH]

Cross-References

ID SourceID
PubMed CID5318457
CHEMBL ID1933684
SCHEMBL ID671838
MeSH IDM0578362

Synonyms (9)

Synonym
aceritannin
[(2r,3s,4s,5s)-3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
CHEMBL1933684
ginnalin a
SCHEMBL671838
aceritannin, >=85% (lc/ms-uv)
2,6-di-o-galloyl-1,5-anhydro-d-glucitol
76746-56-0
AKOS040734387
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID638442Inhibition of yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 10 mins before substrate addition measured after 5 mins by micro-plate reader analysis2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Maplexins, new α-glucosidase inhibitors from red maple (Acer rubrum) stems.
AID638443Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Maplexins, new α-glucosidase inhibitors from red maple (Acer rubrum) stems.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (70.00)24.3611
2020's3 (30.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.15 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]